Cognigen Corporation, a division of Simulations Plus

Advancing the Science and Engineering the Systems of Model-Based Drug Development Cognigen Corporation, a division of Simulations Plus provides strategic clinical pharmacology and pharmacometric consulting services, PK/PD model development, clinical trial simulations, exposure-response evaluations, and related data management services including analysis dataset creation and documentation. Cognigens multidisciplinary scientific teams reliably deliver high quality comprehensive technical reports synthesizing analysis findings to enable knowledge-based decision-making at critical regulatory and drug development milestones. Our PERSPECTIVE Hypertext Data Analysis Mapping software and Internet-based client collaboration strategy allows integrated project teams real-time collaborative review of results and ensures relevant actionable findings

Pk/pd modeling and simulations,pharmacokinetic analyses,data assembly,exposure-response analyses,forensic pharmacometrics,dose justification,pbpk modeling,ctd 272,systems pharmacology,noncompartmental analysis,and nonmem

Cognigen corporation, a division of simulations plus operates in the Pharmaceutical manufacturing industry.

Cognigen corporation, a division of simulations plus's revenue is 11m - 100m

Cognigen corporation, a division of simulations plus has 11 - 50 employees.